Skip to main content

Oxaprozin Side Effects

Medically reviewed by Drugs.com. Last updated on Jun 28, 2023.

Applies to oxaprozin: oral capsule, oral tablet.

Warning

Oral route (Tablet; Capsule)

Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use. Oxaprozin is contraindicated in the setting of coronary artery bypass graft (CABG) surgery. NSAIDs can also cause an increased risk of serious gastrointestinal (GI) adverse events, including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients and patients with a prior history of peptic ulcer disease and/or GI bleeding are at greater risk for serious GI events.

Serious side effects of Oxaprozin

Along with its needed effects, oxaprozin may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking oxaprozin:

More common

Less common

Incidence not known

Other side effects of Oxaprozin

Some side effects of oxaprozin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

Rare

For Healthcare Professionals

Applies to oxaprozin: oral capsule, oral tablet.

General

The most frequently reported adverse effects were gastrointestinal (GI) in nature and included GI pain, anorexia, GI ulcers, heartburn, dyspepsia, nausea, vomiting, diarrhea, constipation, flatulence, and gross bleeding or perforation.[Ref]

Gastrointestinal

Common (1% to 10%): Abdominal pain/distress, anorexia, constipation, diarrhea, dyspepsia, flatulence, gastrointestinal (GI) ulcers, gross bleeding/perforation, heartburn, nausea, vomiting

Frequency not reported: Dry mouth, eructation, esophagitis, gastritis, glossitis, hematemesis, stomatitis, pancreatitis, hemorrhoid bleeding, rectal bleeding, melena[Ref]

Hepatic

Common (1% to 10%): Liver enzymes elevated

Frequency not reported: Jaundice, liver function abnormalities, hepatitis, liver failure[Ref]

Renal

Common (1% to 10%): Abnormal renal function

Frequency not reported: Acute interstitial nephritis, cystitis, renal insufficiency, acute renal failure, nephrotic syndrome, renal calculi[Ref]

Cardiovascular

Frequency not reported: Arrhythmia, blood pressure changes, congestive heart failure, hypertension, hypotension, myocardial infarction, palpitations, tachycardia, syncope, vasculitis[Ref]

Nervous system

Common (1% to 10%): CNS inhibition, somnolence, sedation, dizziness, headache

Frequency not reported: Taste disturbance, coma, convulsions, drowsiness, paresthesia, tremors[Ref]

Dermatologic

Common (1% to 10%): Pruritus, rash

Frequency not reported: Ecchymosis, purpura, alopecia, angioedema, urticaria, photosensitivity, pseudoporphyria, exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, sweating, toxic epidermal necrolysis[Ref]

Hematologic

Common (1% to 10%): Anemia, bleeding time increased

Frequency not reported: Agranulocytosis, aplastic anemia, eosinophilia, hemolytic anemia, lymphadenopathy, pancytopenia, thrombocytopenia, leukopenia[Ref]

Hypersensitivity

Frequency not reported: Hypersensitivity reactions[Ref]

Other

Common (1% to 10%): Edema, tinnitus

Frequency not reported: Death, sepsis, fever, infection, asthenia, malaise, meningitis, vertigo, weakness, hearing decreased[Ref]

Psychiatric

Common (1% to 10%): Depression, confusion, sleep disturbance, dream abnormalities

Frequency not reported: Anxiety, hallucinations, insomnia, nervousness[Ref]

Genitourinary

Common (1% to 10%): Dysuria, urinary frequency

Frequency not reported: Hematuria, menstrual flow increased, oliguria, polyuria, proteinuria, menstrual flow decreased[Ref]

Respiratory

Frequency not reported: Asthma, dyspnea, pulmonary infections, pneumonia, sinusitis, upper respiratory tract infection, respiratory depression[Ref]

Immunologic

Frequency not reported: Serum sickness[Ref]

Metabolic

Frequency not reported: Appetite changes, hyperglycemia, weight changes[Ref]

Ocular

Frequency not reported: Blurred vision, conjunctivitis[Ref]

References

1. Product Information. Daypro (oxaprozin). Searle. 2001;PROD.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.